Animal Microbiome Congress will provide the latest clinical data and key content on the commercialisation of animal microbiome research. The global market is forecasted to grow to $9,775 million by 2028 due to demand for innovation from the rapidly growing meat and pet-healthcare industries.
The event supports smart interactions between business and academia to enable participants to capitalize on the growing global animal microbiome market.
HGF Partner Craig Thomson will be part of the panel
discussion on Enacting a Commercially Successful Strategy
for Animal Microbiome Globally on 3rd March. The panel
will discuss:
- Leveraging the various methodologies and technologies from human microbiome to animal to increase the value of the animal microbiome market
- Understanding the spectrum of commercial opportunities in developing animal microbiome technology for the next decade around the world
- Securing investment to launch a commercial animal microbiome product
- Forming commercially successful partnerships with other animal and human microbiome companies by connecting the innovators with the implementers
Click here to register.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
